Related Experiment Video
Updated: Feb 18, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses.
Javier Burgueño1, Marta Pujol1, Xavier Monroy1
1Department of Pharmacology, Drug Discovery & Preclinical Development, ESTEVE, Barcelona, Spain.
Researchers introduce a new log(τ) scale to better quantify biased agonism in G protein-coupled receptor signaling. This efficacy-driven scale complements existing methods, especially for partial agonists, improving compound classification and understanding functional selectivity.
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- G protein-coupled receptors (GPCRs) exhibit multidimensional signaling.
- Functional selectivity, or biased agonism, describes ligands activating distinct signaling pathways with varying efficacies.
- Current bias quantification using transduction coefficients (log(τ/KA)) can obscure nuanced compound profiles.
Purpose of the Study:
- To introduce a novel efficacy-driven scale, log(τ), for quantifying GPCR ligand bias.
- To complement existing affinity and efficacy-driven scales (log(τ/KA)).
- To improve the classification and characterization of biased agonists, particularly in cases of partial agonism.
Main Methods:
- Development of a theoretical framework for the log(τ) scale.
- Application of the log(τ) scale to analyze μ-opioid receptor agonists.
- Comparison of the log(τ) scale with the traditional log(τ/KA) scale.
Main Results:
- The proposed log(τ) scale provides additional resolution for classifying biased agonists.
- This efficacy-driven parameter offers a complementary view to affinity-driven metrics.
- Demonstrated utility in characterizing partial agonists at the μ-opioid receptor.
Conclusions:
- The log(τ) scale enhances the quantitative assessment of functional selectivity.
- It serves as a valuable adjunct to existing models for understanding biased agonism.
- This approach facilitates a more precise characterization of ligand-biased GPCR signaling.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Related Concept Videos
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Dose-Response Relationship: Overview
Spare Receptors
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...